Citation Impact
Citing Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Annual Rate of Transvenous Defibrillation Lead Defects in Implantable Cardioverter-Defibrillators Over a Period of >10 Years
2007
Effect of QRS Duration and Morphology on Cardiac Resynchronization Therapy Outcomes in Mild Heart Failure
2012
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Baseline Characteristics and Treatment of Patients in Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF)
2014
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Uninterrupted oral anticoagulation versus bridging in patients with long-term oral anticoagulation during percutaneous coronary intervention: subgroup analysis from the WOEST trial
2015
Development and feasibility testing of decision support for patients who are candidates for a prophylactic implantable defibrillator: a study protocol for a pilot randomized controlled trial
2013
Survival in octogenarians receiving implantable defibrillators
2006
Clinical and Electrophysiologic Predictors of Ventricular Tachyarrhythmia Recurrence in Patients with Implantable Cardioverter Defibrillators
2003
Cardiac-Resynchronization Therapy in Heart Failure with a Narrow QRS Complex
2013
Peripartum cardiomyopathy
2006
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
2015
Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: Meta-analysis of randomized controlled trials
2012
Pregnancy outcome and management of women with an implantable cardioverter defibrillator: a single centre experience
2012
Predictors and Risk of Ventricular Tachyarrhythmias or Death in Black and White Cardiac Patients
2016
The ABCD (Alternans Before Cardioverter Defibrillator) Trial
2009
Exercise Standards for Testing and Training
2013 Standout
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
2009 Standout
Surgical epicardial left ventricular lead versus coronary sinus lead placement in biventricular pacing☆
2004
Prevention of inappropriate therapy in implantable cardioverter-defibrillators
2004
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
2005 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Frequency and Causes of Implantable Cardioverter-Defibrillator Therapies: Is Device Therapy Proarrhythmic?
2006
Impact of QRS Duration on Clinical Event Reduction With Cardiac Resynchronization Therapy
2011
Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction
2002 Standout
Four-Year Efficacy of Cardiac Resynchronization Therapy on Exercise Tolerance and Disease Progression
2006
Incidence, Mortality, and Racial Differences in Peripartum Cardiomyopathy
2007
HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials
2014
Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure Symptoms
2008
Cardiac resynchronization therapy in patients with left ventricular systolic dysfunction and right bundle branch block: A systematic review
2011
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Peripartum cardiomyopathy
2009
Myocarditis
2011 Standout
Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure
2004 Standout
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
2018 Standout
Pacemaker implantation and quality of life in the Mode Selection Trial (MOST)
2006
Cardiac Resynchronization and Death From Progressive Heart Failure
2003
Epidemiology of Peripartum Cardiomyopathy
2011
Prevalence and Incidence of Arrhythmias and Sudden Death in Heart Failure
2002
An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure
2013
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
2014 Standout
Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation
2010
Surgery for ventricular tachycardia in patients undergoing surgical ventricular restoration: The Karolinska approach
2007
Left Ventricular‐Based Cardiac Stimulation Post AV Nodal Ablation Evaluation (The PAVE Study)
2005
Nonsustained Ventricular Tachycardia
2012
Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
2003 Standout
Cardiac Resynchronization Therapy in Patients With Atrial Fibrillation
2013
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
2005 Standout
Limitations of Ejection Fraction for Prediction of Sudden Death Risk in Patients With Coronary Artery Disease
2007
Myocarditis
2009 Standout
Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: A systematic review and meta-analysis
2011
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy
2010 Standout
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary
2020
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Superior Cardiovascular Effect of Aerobic Interval Training Versus Moderate Continuous Training in Heart Failure Patients
2007 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Magnesium in Man: Implications for Health and Disease
2014 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2006
Pacemaker and ICD Generator Malfunctions
2006
Decision aids for people facing health treatment or screening decisions
2017 Standout
Chronic Heart Failure in Congenital Heart Disease
2016
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Tissue Doppler Imaging Is Superior to Strain Rate Imaging and Postsystolic Shortening on the Prediction of Reverse Remodeling in Both Ischemic and Nonischemic Heart Failure After Cardiac Resynchronization Therapy
2004
Impact of QRS Morphology and Duration on Outcomes After Cardiac Resynchronization Therapy
2013
Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device
2009 Standout
Worldwide Epidemiology of Atrial Fibrillation
2013 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
Effect of Cardiac Resynchronization Therapy on Left Ventricular Size and Function in Chronic Heart Failure
2003
Systematic Review: Cardiac Resynchronization in Patients with Symptomatic Heart Failure
2004
Cardiac resynchronisation therapy is not associated with a reduction in mortality or heart failure hospitalisation in patients with non-left bundle branch block QRS morphology: meta-analysis of randomised controlled trials
2015
Reviewing Peripartum Cardiomyopathy: Current State of Knowledge
2009
Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy
2012
2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
Cost-Effectiveness of Dual-Chamber Pacing Compared With Ventricular Pacing for Sinus Node Dysfunction
2005
Residual high incidence of ventricular arrhythmias after left ventricular reconstructive surgery
2005
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes
2015
2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
Cardiovascular Outcomes With Atrial-Based Pacing Compared With Ventricular Pacing
2006
Works of Anthony Tang being referenced
Resynchronization/defibrillation for ambulatory heart failure trial: rationale and trial design
2008
Effect of pacing mode on health-related quality of life in the Canadian Trial of Physiologic Pacing
2003
Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure
2010
Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation
2013
Prevalence and significance of lead-related thrombi in patients with implantable cardioverter defibrillators
2003
The problem of non-response to cardiac resynchronization therapy
2005
Electrophysiologic Testing to Identify Patients with Coronary Artery Disease Who Are at Risk for Sudden Death
2000
Bridge or continue Coumadin for device surgery: a randomized controlled trial rationale and design
2008
Frequency of Peripartum Cardiomyopathy
2006
Cardiac resynchronization therapy in advanced heart failure the multicenter InSync clinical study☆
2002
Cardiac Resynchronization Therapy in Patients With Permanent Atrial Fibrillation
2012